StockData

Nutra Pharma Corp (NPHC) income statement

NPHCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 1/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $806.69KP/E –Yield –

Nutra Pharma Corp income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
64.8%
Operating margin
-1017.8%
Net margin
-3370.6%
Return on equity, FY2025
12.9%

Financial strength

Current ratio
0.02
Debt to equity
-0.59
Debt to assets
2018.7%
Cash to current liabilities
–

Valuation

P/E ratio
–
Price to sales
5.02
Price to book
–
Dividend yield
–

See a number that looks wrong?